UPDATE: PTC Therapeutics (PTCT) Gains on Talk Regarding Recommendation of Ataluren

August 25, 2016 11:04 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
(Updated - August 25, 2016 11:11 AM EDT)

PTC Therapeutics (NASDAQ: PTCT) shares were active Thursday as trader circulated a NICE/All Wales update on its ataluren/Translarna recommendation (link).

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment